Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neuroimaging Biomarker-Guided Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Major Depressive Episode in Adolescents and Young Adults with Mood Disorders: a Randomized, Double-Blind, Controlled Study

NCT05465928 is registered in ClinicalTrials.gov with Jiangsu Province Nanjing Brain Hospital as lead sponsor.

NCT NCT05465928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05465928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neuroimaging Biomarker-Guided Personalized Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Major Depressive Episode in Adolescents and Young Adults with Mood Disorders: a Randomized, Double-Blind, Controlled Study
Lead sponsor
Jiangsu Province Nanjing Brain Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 2, 2022
Completion date
January 20, 2024
Enrollment
219 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive episode